drugset / Trial / NCT00427232

Endothelin-Receptor Blockade in Coronary Heart Disease

NCT00427232

Phase 1 Completed 26 enrolled Medical University of Vienna
RandomizedParallel-groupDouble-blindDiagnostic

Summary

Endothelin is a hormon that causes acute and chronic narrowing of heart vessels. The purpose of this study is to assess whether suppression of this activity by using two types of receptor antagonists can reduce this effect and thus improve blood supply of the heart muscle.

Timeline

Start
2003-05
Primary completion
Completion
2006-08

Drugs

EvaluationDrugModalityDoseRoute
Subject BQ-123 Peptide 40 unknown Other
Subject BQ-788 Unknown 10 unknown Other